TORL BioTherapeutics Raises $158M in Series B-2 Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Related Keywords

Los Angeles ,Dennis Slamon ,Mark Alles ,Perceptive Xontogeny Venture Fund ,Bristol Myers Squibb ,Division Of Hematology Oncology ,Slamon Research Lab ,David Geffen School ,Deep Track Capital ,Perceptive Advisors ,Avidity Partners ,Goldman Sachs Alternatives ,Vertex Ventures ,Moore Strategic Ventures ,Blue Owl Healthcare Opportunities ,Perceptive Xontogeny Venture ,Notch Ligand ,Board Member ,Scientific Co Founder ,Geffen School ,